FZD6 and colorectal carcinoma: According to the cytogenetic risk stratification (CRC) and European Leukemia Net (ELN) risk stratification, the proportion of patients with intermediate-risk and poor-/adverse-risk was higher in the high FZD6 expression group than in the low FZD6 expression group (P < 0.001) (Table 1).